σ-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells:: Potential relation to lipid raft reconstitution

被引:74
作者
Takebayashi, M [1 ]
Hayashi, T [1 ]
Su, TP [1 ]
机构
[1] NIDA, IRP, NIH, Cellular Pathobiol Unit,Dev & Plast Sect,Cellular, Baltimore, MD 21224 USA
关键词
EGF; NGF; neurite; ERK; raft; lipid raft; microdomain; cholesterol; sphingolipid; ganglioside; sigma receptor; sigma-1;
D O I
10.1002/syn.20041
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We previously demonstrated that overexpression of sigma-1 receptors (sigma-1R) potentiated neurite sprouting caused by nerve growth factor in PC 12 cells (Takebayashi et al. [2002] J Pharmacol Exp Ther 202:1227-1237). In this study we examined if sigma-1R may be involved in the action of epidermal growth factor (EGF). EGF is conventionally recognized as a mitogenic factor that stimulates only the proliferation of various types of cells, including PC12 cells. We found here that in sigma-1 receptor-overexpressing PC12 cells (sigma-1R OE cells), EGF markedly stimulates neuritogenesis without affecting cellular proliferation. EGF receptors (EGFR) are largely reduced in lipid rafts and are enriched in non-raft regions in sigma-1R OE cells. The enrichment of EGFR in the non-raft region is correlated with enhanced downstream signaling of EGFR including the phosphorylation of both EGFR and extracellular signal-regulated kinases (ERKs). Destruction of cholesterol-containing rafts by treating cells with methyl-beta-cyclodextrin also causes a reduction of EGFR in lipid rafts, a concomitant increase in the phosphorylation of both EGFR and ERK, and an increase in the EGF-induced neurite sprouting in wildtype cells. Furthermore, while overexpression of sigma-1R increases the level of lipid raft-associated cholesterol, the overexpression alters the levels of gangliosides in lipid rafts: GM1 and GM2 are decreased, whereas GD1a is increased. We conclude that sigma-1R cause the remodeling of lipid rafts, at least by increasing the level of lipid raft-associated cholesterol and by altering the levels of certain critical lipid raft-forming gangliosides. sigma-1R may thus play an important role in directing EGF signaling towards neuritogenesis, perhaps by shifting EGFR from the lipid raft into non-raft regions. Published 2004 Wiley-Liss, Inc.
引用
收藏
页码:90 / 103
页数:14
相关论文
共 46 条
[31]   Modulation of phosphoinositide 3-kinase activation by cholesterol level suggests a novel positive role for lipid rafts in lysophosphatidic acid signalling [J].
Peres, C ;
Yart, A ;
Perret, B ;
Salles, JP ;
Raynal, P .
FEBS LETTERS, 2003, 534 (1-3) :164-168
[32]   Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking [J].
Pike, LJ ;
Casey, L .
BIOCHEMISTRY, 2002, 41 (32) :10315-10322
[33]   A PROPOSAL FOR THE CLASSIFICATION OF SIGMA BINDING-SITES [J].
QUIRION, R ;
BOWEN, WD ;
ITZHAK, Y ;
JUNIEN, JL ;
MUSACCHIO, JM ;
ROTHMAN, RB ;
SU, TP ;
TAM, SW ;
TAYLOR, DP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (03) :85-86
[34]   STAUROSPORINE CAUSES EPIDERMAL GROWTH-FACTOR TO INDUCE DIFFERENTIATION IN PC12 CELLS VIA RECEPTOR UP-REGULATION [J].
RAFFIONI, S ;
BRADSHAW, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7568-7572
[35]   Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding [J].
Roepstorff, K ;
Thomsen, P ;
Sandvig, K ;
van Deurs, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) :18954-18960
[36]   Accumulation of cholesterol and GM2 ganglioside in cells cultured in the presence of progesterone:: an implication for the basic defect in Niemann-Pick disease type C [J].
Sato, M ;
Akaboshi, S ;
Katsumoto, T ;
Taniguchi, M ;
Higaki, K ;
Tai, T ;
Sakuraba, H ;
Ohno, K .
BRAIN & DEVELOPMENT, 1998, 20 (01) :50-52
[37]  
SEFANSKI R, 2004, PSYCHOPHARMACOLOGY, DOI DOI 10.1007/S00213-004-1779-9
[38]   Lipid rafts and signal transduction [J].
Simons, K ;
Toomre, D .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :31-39
[39]  
Snyder S H, 1989, J Neuropsychiatry Clin Neurosci, V1, P7
[40]  
SU TP, 1988, EUR J PHARMACOL, V148, P467